The DOI matches its Crossref record; 0 of the 1 references it cites were found in a registry or an index.
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Abstract
Bacterial infection of the mammalian bloodstream can lead to overwhelming sepsis, a potentially fatal syndrome of irreversible cardiovascular collapse (shock) and critical organ failure. Cachectin, also known as tumour necrosis factor, is a macrophage-derived peptide hormone released in response to bacterial lipopolysaccharide, and it has been implicated as a principal mediator of endotoxic shock, although its function in bacterial sepsis is not known. Anaesthetized baboons were passively immunized against endogenous cachectin and subsequently infused with an LD100 dose of live Escherichia coli. Control animals (not immunized against cachectin) developed hypotension followed by lethal renal and pulmonary failure. Neutralizing monoclonal anti-cachectin antibody fragments (F(ab')2) administered to baboons only one hour before bacterial challenge protected against shock, but did not prevent critical organ failure. Complete protection against shock, vital organ dysfunction, persistent stress hormone release and death was conferred by administration of antibodies 2 h before bacterial infusion. These results indicate that cachectin is a mediator of fatal bacteraemic shock, and suggest that antibodies against cachectin offer a potential therapy of life-threatening infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TNF is produced during Gram-negative bacteria-induced acute septic shock (3).”
From Physiology and immunology of the cholinergic antiinflammatory pathway (2007) · cites this paper as [3]
In the citing paper
“Consider as one example the case of TNF, a cytokine implicated as a necessary and sufficient mediator of lethal septic shock caused by infection with Gram-negative bacteria.”
From Physiology and immunology of the cholinergic antiinflammatory pathway (2007) · cites this paper as [3]
Citations
Cites
1. Kreger, B. E. W., Craven, D. E. & McCabe, W. R. Am. J. Med. 68, 344-355 (1980). 2. Ziegler, E. J. el al New Engl. J. Med, 307, 1225-1230 (1982). 3. Gilbert, R. P. Physiol. Rev. 40, 245-279 (1960). 4. Beutler, B. & Cerami, A. Nature 320, 584-588 (1986). 5. Beutler, B. & Cerami, A. New Engl. J. Med
(n.d.)
Unresolved
Flagged first, then by citations
1 of the 1 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,001
Karkar, A. M., Koshino, Y., Cashman, S. J., Dash, A., Bonnefoy, J., Meager, A., & Rees, A. J. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb07948.x · Cited by 62
Heller, J., Sogni, P., Barrière, É., Tazi, K. A., Chauvelot‐Moachon, L., Guimont, M.-C., Bories, P. N., Poirel, O., Moreau, R., & Lebrec, D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80272-x · Cited by 62
Wollenberg, G. K., DeForge, L. E., Bolgos, G. L., & Remick, D. G. (1993) · PubMed Central · Cited by 62
Marsters, S. A., Frutkin, A. D., Simpson, N. J., FENDLY, B. M., & Ashkenazi, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42615-4 · Cited by 62
Danner, R. L., Natanson, C., Elin, R. J., Hosseini, J. M., Banks, S. M., MacVittie, T. J., & Parrillo, J. E. (1990) · CHEST Journal · doi:10.1378/chest.98.6.1480 · Cited by 62
Potentia Hazards of Combination Immunotherapy in the Treatment of Experimental Septic Shock
Opal, S. M., Cross, A. S., Jhung, J. W., Young, L. D., Palardy, J., Parejo, N. A., & Donsky, C. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.6.1415 · Cited by 62
Karkar, A. M., Tam, F. W. K., Steinkasserer, A., Kurrle, R., Langner, K., Scallon, B. J., Meager, A., & Rees, A. J. (1995) · Kidney International · doi:10.1038/ki.1995.472 · Cited by 61
Antonelli, M. M., Bonten, M. J. M., Chastre, J. E., Citerio, G., Conti, G., Curtis, J. R., Backer, D. D., Hedenstierna, G., Joannidis, M., Macrae, D. J., et al. (2012) · Intensive Care Medicine · doi:10.1007/s00134-011-2447-2 · Cited by 62
CURRENT CONCEPTS OF SEPSIS AND ACUTE LUNG INJURY
Sessler, C. N., Bloomfield, G. L., & Fowler, A. A. (1996) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70310-5 · Cited by 61
Cholinergic Regulatory Lymphocytes Re-Establish Neuromodulation of Innate Immune Responses in Sepsis
Peña, G., Cai, B., Ramos, L., Vida, G., Deitch, E. A., & Ulloa, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100013 · Cited by 61
Nozaki, N., Yamaguchi, S., Shirakabe, M., Nakamura, H., & Tomoike, H. (1997) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.61.657 · Cited by 61
Peptide-directed Suppression of a Pro-inflammatory Cytokine Response
Liu, X. Y., Robinson, D., Veach, R. A., Liu, D., Timmons, S., Collins, R. D., & Hawiger, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000083200 · Cited by 61
Estriol sensitizes rat Kupffer cells via gut-derived endotoxin
Enomoto, N., Yamashina, S., Schemmer, P., Rivera, C. A., Bradford, B. U., Enomoto, A., Brenner, D. A., & Thurman, R. G. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.3.g671 · Cited by 60
“Increased TNF-a plays a pivotal role in endotoxin shock and related multiple organ failure (28), and anti-TNF-a antibody prevents it (29).”
BackgroundEvans, C. A., Jellis, J. E., Hughes, S. P. F., Remick, D. G., & Friedland, J. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/515313 · Cited by 60
Tumor Necrosis Factor Induces Adult Respiratory Distress Syndrome in Rats
Ferrari‐Baliviera, E. (1989) · Archives of Surgery · doi:10.1001/archsurg.1989.01410120046010 · Cited by 61
Establishment of the role of IL‐6 and TNF receptor 1 using gene knockout mice
Bluethmann, H., Rothe, J., Schultze, N., Tkachuk, M., & Koebel, P. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.5.565 · Cited by 67
Reversal of the toxic effects of cachectin by concurrent insulin administration
Fraker, D. L., Merino, M. J., & Norton, J. A. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.6.e725 · Cited by 61
Abdellatif, A. A. H., Rasheed, Z., Alhowail, A. H., Alqasoumi, A. A., Alsharidah, M. S., Khan, R. A., Aljohani, A. S. M., Aldubayan, M. A., & Faisal, W. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s274098 · Cited by 61
Báfica, A. L. B., Feng, C. G., Santiago, H. C., Aliberti, J., Cheever, A. W., Thomas, K. E., Taylor, G. A., Vogel, S. N., & Sher, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5514 · Cited by 58
Tachado, S. D., Zhang, J., Zhu, J., Patel, N. R., & Koziel, H. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0341oc · Cited by 60
“Recognizing that an effective host response to infection requires a balanced regulation of TNF- (the absence of TNF- resulted in increased morbidity and mortality [46–48], whereas too vigorous a TNFresponse was associated with septic shock and death [49]) data from the current study support the concept that alveolar m…”
BackgroundExpression of TNF-α by human plasma cells in chronic inflammation
Girolamo, N. D., Visvanathan, K., Lloyd, A. R., et al. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.6.667 · Cited by 60
“Immunoreactivity for TNF-a in Tissue Sections From Patients with Chronic Inflammatory Diseases (1-11) and Non-Inflammatory Disorders (23 and 24)”
BackgroundBridging translation for acute kidney injury with better preclinical modeling of human disease
Skrypnyk, N. I., Siskind, L. J., Faubel, S., & de Caestecker, M. P. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00552.2015 · Cited by 61
The Effect of Aging on Circulating Levels of Proinflammatory Cytokines During Septic Shock
Marik, P. E., Zaloga, G. P., & and the Norasept II Study Investigators (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49003.x · Cited by 58
“25 In summary, adults older than 18 years admitted to hospital with septic shock and who met all the following criteria were eligible for enrollment: (1) duration of shock , 12 hours, (2) clinical evidence of acute infection, (3) hyperthermia or hypothermia, (4) tachycardia, (5) need for mechanical ventilation or tach…”
Monoclonal antibodies to human tumor necrosis factor α: In vitro and in vivo application
Möller, A., Emling, F., Blohm, D. H., Schlick, E., & Schollmeier, K. (1990) · Cytokine · doi:10.1016/1043-4666(90)90011-h · Cited by 59
Dorinsky, P., & Gadek, J. E. (1990) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00757-7 · Cited by 60
Transforming growth factor-β in the regulation of the immune response
Sasaki, H., Pollard, R. B., Schmitt, D. A., & Suzuki, F. (1992) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(92)90241-f · Cited by 60
Mueller, Y. M., Schrama, T. J., Ruijten, R., Schreurs, M. W. J., Grashof, D. G. B., van de Werken, H. J. G., Lasinio, G. J., Álvarez‐Sierra, D., Kiernan, C. H., Eiro, M. D. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28621-0 · Cited by 58
DED or alive: assembly and regulation of the death effector domain complexes
Riley, J. S., Malik, A., Holohan, C., & Longley, D. B. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.213 · Cited by 60
HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis
Andersson, U., & Tracey, K. J. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.04.007 · Cited by 59
Self-citationC1 Inhibitor-Mediated Protection from Sepsis
Liu, D., Lu, F., Qin, G., Fernandes, S. M., Li, J., & Davis, A. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3966 · Cited by 61
Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome
Erkan, D. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.06.013 · Cited by 59
Nolte, M. A., LeibundGut‐Landmann, S., Joffre, O. P., & Sousa, C. R. E. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070325 · Cited by 63
Suppression of Human Alveolar Macrophage-derived Cytokines by Amiloride
Rolfe, M. W., Kunkel, S. L., Rowens, B., Standiford, T. J., Cragoe, E. J., & Strieter, R. M. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/6.6.576 · Cited by 59
Rennick, D. M., Berg, D., & Holland, G. (1992) · Progress in Growth Factor Research · doi:10.1016/0955-2235(92)90020-i · Cited by 57
Tumor necrosis factor-α as a myocardial depressant substance
Odeh, M. (1993) · International Journal of Cardiology · doi:10.1016/0167-5273(93)90053-j · Cited by 58
Zuckerman, S. H., & Bendele, A. M. (1989) · Infection and Immunity · doi:10.1128/iai.57.10.3009-3013.1989 · Cited by 59
“The appearance of TNF in the serum of mice, rabbits, and baboons following infusion of Escherichia coli or endotoxin and the ability of anti-TNF antibodies to protect these animals from death support the hypothesis that TNF has a role in septic shock (3, 16, 24, 25).”
BackgroundAcute effects of tumor necrosis factor on the microcirculation in rat cremaster muscle.
Vicaut, É., Hou, X., Payen, D. M., Bousseau, A., & Tedgui, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115165 · Cited by 59
Cachectin/tumor necrosis factor and other cytokines in infectious disease
Tracey, K. J., & Cerami, A. (1989) · Current Opinion in Immunology · doi:10.1016/0952-7915(88)90026-x · Cited by 58
Self-citationVadas, P., Scott, K. F., Smith, G., et al. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90186-s · Cited by 59
Inhibitory Effects of Interleukin 6 on Immunity
Zhou, D. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420010079011 · Cited by 59
Zhang, W., Wojta, J., & Binder, B. R. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.3.465 · Cited by 58
Anti-Inflammatory Effects of Lysozyme Against HMGB1 in Human Endothelial Cells and in Mice
Lee, W., Ku, S., Na, D. H., & Bae, J. (2015) · Inflammation · doi:10.1007/s10753-015-0171-8 · Cited by 58
“However, the early kinetics of systemic TNF-α accumulation makes its targeting difficult in the clinical setting [54], which prompted the investigation of other late proinflammatory mediators such as HMGB1 as potential therapeutic targets for inflammatory diseases.”
BackgroundGender dimorphism following injury: making the connection from bench to bedside
Sperry, J. L., & Minei, J. P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607360 · Cited by 59
IMMUNOLOGIC RESPONSE TO INFECTION AND ITS ROLE IN SEPTIC SHOCK
Casey, L. C. (2000) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70107-x · Cited by 58
Gosain, A., & Gamelli, R. L. (2005) · Journal of Burn Care & Rehabilitation · doi:10.1097/01.bcr.0000150214.72984.44 · Cited by 59
de Vos, A. F., Haren, M. A. C. V., Verhagen, C., et al. (1995) · Experimental Eye Research · doi:10.1016/s0014-4835(05)80017-x · Cited by 58
Thejass, P., & Kuttan, G. (2006) · Phytomedicine · doi:10.1016/j.phymed.2006.09.013 · Cited by 58
Role of Tumor Necrosis Factor in Sepsis and Acute Lung injury
Simpson, S. Q., & Casey, L. C. (1989) · Critical Care Clinics · doi:10.1016/s0749-0704(18)30449-4 · Cited by 58
Abraham, E. H., Jesmok, G. J., Tuder, R. M., et al. (1995) · Critical Care Medicine · doi:10.1097/00003246-199508000-00004 · Cited by 58
Vanderheyden, M. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0828 · Cited by 57
“Although the pro-inflammatory cytokine levels in our study were lower compared to those observed during sepsis([16]) and endotoxaemia([17]), they appear elevated compared to normal healthy subjects([1]) and are similar to those previously reported in patients with NYHA II and III heart failure([1,18]).”
BackgroundResultCapon, S. M., & Goldfinger, D. (1995) · Transfusion · doi:10.1046/j.1537-2995.1995.35695288773.x · Cited by 58
Tumor Necrosis Factor in Septicemic Melioidosis
Suputtamongkol, Y., Kwiatkowski, D. P., Dance, D. A. B., Chaowagul, W., & White, N. J. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.3.561 · Cited by 58
Trial Watch—Immunostimulation with cytokines in cancer therapy
Vacchelli, E., Aranda, F., Bloy, N., Buqué, A., Cremer, I., Eggermont, A. M. M., Fridman, W. H., Fucikova, J. P., Galon, J., Špíšek, R., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1115942 · Cited by 60
Experimental Human Endotoxemia: A Model of the Systemic Inflammatory Response Syndrome?
Calvano, S. E., & Coyle, S. M. (2012) · Surgical Infections · doi:10.1089/sur.2012.155 · Cited by 57
Ito, K., Mizutani, A., Kira, S., et al. (2004) · Injury · doi:10.1016/j.injury.2004.06.018 · Cited by 57
Sepsis Induced by Cecal Ligation and Puncture
Wen, H. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-481-4_15 · Cited by 57
“Although experimental studies using animal models of sepsis have documented a beneficial effect of these therapies (18-22), subsequent clinical trials were disappointing since they showed no substantial benefits (23-27).”
Zhu, S., Li, W., Ward, M. F., Sama, A. E., & Wang, H. (2010) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152810791292872 · Cited by 57
Gurung, P., Rai, D., Condotta, S. A., Babcock, J. C., Badovinac, V. P., & Griffith, T. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101180 · Cited by 57
Melatonin effects on inhibition of thirst and fever induced by lipopolysaccharide in rat
Nava, F. A., Calapai, G., Facciolà, G., Cuzzocrea, S., Giuliani, G., Sarro, A. D., & Caputi, A. P. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01049-2 · Cited by 56
Potential Therapeutic Role of Cationic Peptides in Three Experimental Models of Septic Shock
Giacometti, A., Cirioni, O., Ghiselli, R., Mocchegiani, F., Prete, M. S. D., Viticchi, C., Kamysz, W., Łempicka, E., Saba, V., & Scalise, G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2132-2136.2002 · Cited by 57
“Nevertheless, it is known that many antibiotics used clinically can be harmful when administered for the treatment of severe infections cause by gram-negative bacteria, in that they can stimulate the release of endotoxin and thus increase the rates of occurrence of symptoms and life-threatening complications (4, 21, 2…”
BackgroundTargeting high mobility group box 1 as a late-acting mediator of inflammation
Czura, C. J., & Tracey, K. J. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301001-00007 · Cited by 57
“Targeting the early and rapid kinetics of these mediators is particularly problematic in the clinic, because even a minimal delay reduces the efficacy of this treatment approach (2).”
BackgroundSelf-citationVallespí, M. G., Alvarez‐Obregón, J. C., Rodríguez-Alonso, I., Montero, T., Garay, H., Reyes, O., & Araña, M. J. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00277-1 · Cited by 57
Insulin Attenuates Apoptosis and Exerts Anti-Inflammatory Effects in Endotoxemic Human Macrophages
Leffler, M., Hrach, T., Stürzl, M., Horch, R. E., Herndon, D. N., & Jeschke, M. G. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.01.030 · Cited by 58
Schmid‐Schönbein, G. W., & Hugli, T. E. (2005) · Microcirculation · doi:10.1080/10739680590896009 · Cited by 57
The systemic inflammatory response syndrome (SIRS): Immunology and potential immunotherapy
Darville, T. L., Jacobs, R. F., & Giroir, B. P. (1993) · Infection · doi:10.1007/bf01712446 · Cited by 55
Medan, D., Wang, L., Yang, X., Dokka, S., Castranova, V., & Rojanasakul, Y. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10105 · Cited by 57
“Previous studies have indicated that the cytotoxic effect of LPS is mediated through the induction of proinflammatory cytokines, most notably TNF-a (Tracey et al., 1987; Ulich et al., 1991; Suter et al., 1992).”
BackgroundLeukocytes, the Janus cells in inflammatory disease
Nussler, A. K., Wittel, U. A., Nüssler, N. C., & Beger, H. G. (1999) · Langenbeck s Archives of Surgery · doi:10.1007/s004230050196 · Cited by 57
Tumor Necrosis Factor in Humans
Ziegler, E. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182309 · Cited by 57
Eggimann, P., Chioléro, R. L., Chassot, P., Líénard, D., Gérain, J., & Lejeune, F. J. (1995) · CHEST Journal · doi:10.1378/chest.107.4.1074 · Cited by 57
The Physiologic Basis for Anticytokine Clinical Trials in the Treatment of Sepsis 1
Cain, B. S., Meldrum, D. R., Harken, A. H., & McIntyre, R. C. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00036-2 · Cited by 57
Bitterman, H., Kinarty, A., Lazarovich, H., et al. (1991) · Journal of Clinical Immunology · doi:10.1007/bf00917424 · Cited by 57
“... and TNF activities are increased in animals and humans after lipopolysaccharide (LPS) injection and in sepsis (8), and a correlation between high cytokine levels and a poor prognosis has been demonstrated (7, 4); (ii) cytokine administration duplicates many of the pathophysiological features of septic shock (9), a…”
BackgroundBertoni, G., Kuhnert, P., Peterhans, E., et al. (1993) · Journal of Immunological Methods · doi:10.1016/0022-1759(93)90187-c · Cited by 57
Flory, C. M., Jones, M. L., Miller, B. F., et al. (1995) · PubMed · Cited by 57
TNF-α in Uveitis: From Bench to Clinic
Jiang, Q., Li, Z., Tao, T., Duan, R., Wang, X., & Su, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.740057 · Cited by 59
Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-α
Hikita, A., Tanaka, N., Yamane, S., Ikeda, Y., Furukawa, H., Tohma, S., Suzuki, R., Tanaka, S., Mitomi, H., & Fukui, N. (2009) · Biochemistry and Cell Biology · doi:10.1139/o09-015 · Cited by 56
“87: 581–593 (2009) doi:10.1139/O09-015 Published by NRC Research Press such as rheumatoid arthritis, osteoarthritis, Crohn’s disease, and endotoxin shock (Tracey et al. 1987; Kriegler et al. 1988; Brennan et al. 1989; Reinecker et al. 1993; Fernandes et al. 2002).”
InfluentialSpontaneous NF-κB Activation by Autocrine TNFα Signaling: A Computational Analysis
Pȩkalski, J., Żuk, P. J., Kochańczyk, M., Junkin, M., Kellogg, R., Tay, S., & Tomasz Lipniacki, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078887 · Cited by 57
Multiple Organ Failure: A Common Problem in Surgical Intensive Care Unit Patients
Livingston, D. H., & Deitch, E. A. (1995) · Annals of Medicine · doi:10.3109/07853899509031931 · Cited by 55
Premise for Standardized Sepsis Models
Remick, D. G., Ayala, A., Chaudry, I. H., Coopersmith, C. M., Deutschman, C. S., Hellman, J., Moldawer, L. L., & Osuchowski, M. F. (2018) · Shock · doi:10.1097/shk.0000000000001164 · Cited by 61
“As one specific example, findings from an animal model led to the development of antibodies to TNF for the treatment of sepsis (70).”
ResultNQO1 inhibits the TLR-dependent production of selective cytokines by promoting IκB-ζ degradation
Kimura, A., Kitajima, M., Nishida, K., Serada, S., Fujimoto, M., Naka, T., Fujii‐Kuriyama, Y., Sakamato, S., Ito, T., Handa, H., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172024 · Cited by 58
“20172024 2198 proinflammatory cytokines can prevent the development of septic shock in animal models (Tracey et al., 1987; Riedemann et al., 2003), the neutralizing of TNF-α or IL-1β had no sufficient clinical effects in critically ill patients (Fisher et al.”
BackgroundSTRUCTURE-FUNCTION RELATIONSHIPS OF BACTERIAL ENDOTOXINS
Morrison, D. C., Silverstein, R., Luchi, M., & Shnyra, A. A. (1999) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70077-5 · Cited by 55
van der Poll, T., Jansen, P. M., Zee, K. J. V., Welborn, M. B., de Jong, I., Hack, C. E., Loetscher, H., Lesslauer, W., Lowry, S. F., & Moldawer, L. L. (1996) · PubMed · doi:10.1182/blood.v88.3.922.922 · Cited by 55
Self-citationPlaen, I. G. D., Tan, X., Chang, H., Wang, L., Remick, D. G., & Hsueh, W. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703055 · Cited by 56
“Another central mediator of endotoxin shock is TNF (Tracey et al., 1987) which is known to activate p50-p65 and p50-c-Rel in vitro (Beg et al., 1994).”
BackgroundBeutler, B., & Brown, T. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115137 · Cited by 55
Tumour necrosis factor and bacterial sepsis
MICHIE, H. R., Guillou, P. J., & Wilmore, D. W. (1989) · British journal of surgery · doi:10.1002/bjs.1800760706 · Cited by 54
Crucial Role of TNF Receptors 1 and 2 in the Control of Polymicrobial Sepsis
Sécher, T., Vasseur, V., Poisson, D. M., Mitchell, J. A., Cunha, F. Q., Alves-Filho, J. C., & Ryffel, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804008 · Cited by 55
“TNF inhibitors protect mice from sepsis induced by LPS or bacteria inoculation (14, 15).”
BackgroundRupert waterhouse and carl friderichsen: adrenal apoplexy
Varón, J., Chen, K. S., & Sternbach, G. L. (1998) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(98)00061-4 · Cited by 55
van der Poll, T. (2012) · Surgical Infections · doi:10.1089/sur.2012.105 · Cited by 55
“In a hallmark manuscript resulting from a collaborative effort of the research groups led by Anthony Cerami and Stephen F. Lowry, elimination of the prototypic pro-inflammatory cytokine tumor necrosis factor (TNF)- a was reported to protect baboons against lethal gram-negative sepsis [4].”
Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice
Wang, H., Liu, H., Jia, Z., Olsen, C. D., Litwin, S. E., Guan, G., & Yang, T. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00439.2009 · Cited by 55
“Along this line, TNF- neutralization with a TNF- antibody or a TNF- -soluble receptor (TNFsRp55) protects against septic shock in baboons (43) and mice (6, 25).”
BackgroundOrientin Inhibits HMGB1-Induced Inflammatory Responses in HUVECs and in Murine Polymicrobial Sepsis
Yoo, H., Ku, S., Lee, T., & Bae, J. (2014) · Inflammation · doi:10.1007/s10753-014-9899-9 · Cited by 55
“For instance, neutralizing antibodies against TNF [74] reduces lethality in an animal model of endotoxemic/bacteremic shock.”
BackgroundNaikawadi, R. P., Cheng, N., Vogel, S. M., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.273078 · Cited by 55
Complement-related molecular events in sepsis leading to heart failure
Hoesel, L. M., Niederbichler, A. D., & Ward, P. A. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.06.009 · Cited by 54
Dinges, M. M., & Schlievert, P. M. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1256-1264.2001 · Cited by 55
“animal models (3, 43, 71), demonstrating that TNF-a is a”
MethodAdi, S., Pollock, A. S., Shigenaga, J. K., et al. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115755 · Cited by 55
Wakefield, C. H., Barclay, G. R., Fearon, K. C. H., Goldie, A. S., Ross, J. A., Grant, I. S., Ramsay, G., & Howie, J. C. (1998) · British journal of surgery · doi:10.1046/j.1365-2168.1998.00710.x · Cited by 55
He, W., Fong, Y., Marano, M. A., Gershenwald, J. E., Yurt, R. W., Moldawer, L. L., & Lowry, S. F. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.5.859 · Cited by 54
Self-citationCiacci-Woolwine, F., McDermott, P. F., & Mizel, S. B. (1999) · Infection and Immunity · doi:10.1128/iai.67.10.5176-5185.1999 · Cited by 55
“Animal models have shown that host-derived inflammatory mediators such as TNFa promote the strong inflammatory response observed during Salmonella infection of the intestinal mucosa (2, 6, 38, 39 ).”
BackgroundJunquero, D. C., Scott‐Burden, T., Schini, V. B., et al. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019273 · Cited by 55
The Efficacy of Combination Immunotherapy in Experimental Pseudomonas Sepsis
Cross, A. S., Opal, S. M., Palardy, J., et al. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.1.112 · Cited by 55
Nandi, D., Mishra, M. K., Basu, A., & Bishayi, B. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.08.003 · Cited by 55
Yang, C. L.-H., Chik, S. C. C., Li, J., Cheung, B. K. W., & Lau, A. S. Y. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9006164 · Cited by 54
Metadata
- Authors
- Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A.
- Affiliations
- Cornell University (US)
- Rockefeller University (US)
- Venue
- Nature
- Published
- 1987-12
- Volume
- 330
- Issue
- 6149
- Pages
- 662-664
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2038434279
- Cited by
- 2,448
- References
- 1
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 19 · 2023: 17 · 2022: 13 · 2021: 24 · 2020: 24 · 2019: 32 · 2018: 31 · 2017: 24 · 2016: 40 · 2015: 33 · 2014: 44 · 2013: 43 · 2012: 46
- FWCI
- 95.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TNF-α, septic shock, bacteremia, Escherichia coli, passive immunization, neutralizing monoclonal antibodies, F(ab')2 fragments, endotoxic shock, organ failure, renal failure, respiratory failure, stress hormones, baboons, sepsis treatment
- MeSH terms
- Animals, Antibodies, Monoclonal, Blood Pressure, Cardiac Output, Catecholamines, Glucagon, Immunization, Passive, Immunologic Techniques, Leukocyte Count, Papio, Shock, Septic, Tumor Necrosis Factor-alpha, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review